Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John B Sunwoo

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Cell Cycle (Georgetown, Tex.)|October 4, 2011
A cisplatin-resistant subpopulation of mesenchymal-like cells in head and neck squamous cell carcinomaJohn B Sunwoo
Hematology/Oncology Clinics of North America|November 17, 2015
Immunotherapy for Head and Neck Squamous Cell CarcinomaDavid W Schoppy, John B Sunwoo
Endocrinology and Metabolism (Seoul, Korea)|July 2, 2019
Natural Killer Cells and Thyroid DiseasesEun Kyung Lee, John B Sunwoo
Oral Oncology|May 31, 2016
Head and neck cancer immunology and immunotherapeutics: Basic concepts to clinical translational approachesRavindra Uppaluri, R Bryan Bell, John B Sunwoo
World Journal of Otorhinolaryngology - Head and Neck Surgery|July 24, 2019
Implementation of a targeted HPV educational program in a population with HIVNoel Ayoub, John B Sunwoo, Heather M Starmer
Journal for Immunotherapy of Cancer|May 17, 2022
Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cellsSainiteesh Maddineni, John L Silberstein, John B Sunwoo
Cancer Journal (Sudbury, Mass.)|November 26, 2013
Cancer immunosurveillance and immunoediting by natural killer cellsEmilie Gross, John B Sunwoo, Jack D Bui
Biochemistry and Biophysics Reports|October 26, 2016
Transcription factor Dlx3 induces aryl hydrocarbon receptor promoter activityJune Ho Shin, Mikel D Haggadone, John B Sunwoo
Laryngoscope Investigative Otolaryngology|February 23, 2026
Patterns of Influenza Vaccination in Head and Neck Cancer Patients in the United StatesMaxwell Y Lee, John B Sunwoo, Michelle M Chen
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2015
CCR 20th anniversary commentary: Preclinical study of proteasome inhibitor bortezomib in head and neck cancerClint T Allen, Barbara Conley, John B Sunwoo, et al.
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Cell Cycle (Georgetown, Tex.)|October 4, 2011
A cisplatin-resistant subpopulation of mesenchymal-like cells in head and neck squamous cell carcinomaJohn B Sunwoo
Hematology/Oncology Clinics of North America|November 17, 2015
Immunotherapy for Head and Neck Squamous Cell CarcinomaDavid W Schoppy, John B Sunwoo
Endocrinology and Metabolism (Seoul, Korea)|July 2, 2019
Natural Killer Cells and Thyroid DiseasesEun Kyung Lee, John B Sunwoo
Oral Oncology|May 31, 2016
Head and neck cancer immunology and immunotherapeutics: Basic concepts to clinical translational approachesRavindra Uppaluri, R Bryan Bell, John B Sunwoo
World Journal of Otorhinolaryngology - Head and Neck Surgery|July 24, 2019
Implementation of a targeted HPV educational program in a population with HIVNoel Ayoub, John B Sunwoo, Heather M Starmer
Journal for Immunotherapy of Cancer|May 17, 2022
Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cellsSainiteesh Maddineni, John L Silberstein, John B Sunwoo
Cancer Journal (Sudbury, Mass.)|November 26, 2013
Cancer immunosurveillance and immunoediting by natural killer cellsEmilie Gross, John B Sunwoo, Jack D Bui
Biochemistry and Biophysics Reports|October 26, 2016
Transcription factor Dlx3 induces aryl hydrocarbon receptor promoter activityJune Ho Shin, Mikel D Haggadone, John B Sunwoo
Laryngoscope Investigative Otolaryngology|February 23, 2026
Patterns of Influenza Vaccination in Head and Neck Cancer Patients in the United StatesMaxwell Y Lee, John B Sunwoo, Michelle M Chen
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2015
CCR 20th anniversary commentary: Preclinical study of proteasome inhibitor bortezomib in head and neck cancerClint T Allen, Barbara Conley, John B Sunwoo, et al.
Pageof 10